Max Healthcare Institute Limited has informed the Exchange regarding a press release dated May 20, 2025, titled "Max Healthcare Q4 revenue soars by +29% YoY to INR 2,429 Cr; Operating EBITDA rises to INR 632 Cr, +26% YoY; PAT grows by +21% YoY to INR 376 Cr".
MAXHEALTH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Max Healthcare reported robust Q4 FY25 results with consolidated revenue rising 29% year-on-year to INR 2,429 crore. Operating EBITDA grew 26% YoY to INR 632 crore, reflecting sustained operational strength. Profit after tax (PAT) increased 21% YoY to INR 376 crore, indicating healthy bottom-line growth. The performance was shared with the exchange via a press release dated May 20, 2025. Overall, the hospital chain posted double-digit growth across revenue, profitability, and earnings metrics.
Strong quarterly performance with broad-based growth across revenue and profitability is likely to be viewed positively by investors and could support short-term stock price sentiment.